World's first biomarker-driven pain & metabolic clinic.
Cartilage Oligomeric Matrix Protein (COMP) is an important biomarker used to evaluate cartilage health and joint degeneration. COMP is a structural protein found primarily in cartilage, tendons, ligaments, and other connective tissues. When cartilage begins to break down due to injury, aging, or arthritis, COMP is released into the bloodstream.
Because COMP reflects cartilage turnover, it provides valuable insight into joint damage before significant structural changes become visible on imaging studies. It is increasingly being studied as a biomarker for osteoarthritis progression, sports injuries, and other musculoskeletal disorders.
For individuals experiencing chronic joint pain, stiffness, or reduced mobility, COMP can offer additional information about ongoing cartilage degeneration.
Cartilage Oligomeric Matrix Protein (COMP) is a non-collagen extracellular matrix protein that plays an important role in maintaining the structural integrity of cartilage.
It helps organize collagen fibers, supports cartilage strength, and contributes to healthy joint function. Under normal conditions, only small amounts of COMP circulate in the bloodstream. However, when cartilage undergoes excessive wear, injury, or inflammation, larger quantities are released into the blood.
Because of this relationship, COMP has become a valuable biomarker for monitoring cartilage health and disease progression.
Unlike X-rays or MRI scans that visualize structural damage, COMP provides biochemical information about active cartilage breakdown.
Healthy cartilage allows joints to move smoothly while absorbing mechanical stress.
As cartilage deteriorates, joint function gradually declines, increasing pain and limiting mobility.
Measuring COMP helps healthcare providers:
Elevated COMP levels may indicate increased cartilage breakdown requiring further evaluation.
Unlike routine laboratory tests, there is currently no universal reference range for COMP because values vary depending on the laboratory, testing method, age, physical activity, and overall health.
Healthcare providers generally interpret COMP results by considering:
Monitoring trends in COMP levels is often more clinically useful than relying on a single measurement.
Elevated COMP levels suggest increased cartilage turnover or cartilage breakdown somewhere in the body.
Common causes include:
A high COMP level does not diagnose a specific condition but indicates that cartilage metabolism may be altered.
Low COMP levels are generally not considered harmful.
Lower values may simply reflect healthy cartilage with minimal breakdown.
COMP is primarily useful when elevated or when changes over time are monitored during treatment or disease progression.
COMP itself does not cause symptoms.
Symptoms result from the underlying condition affecting cartilage.
Common symptoms include:
Individuals with cartilage degeneration often experience worsening symptoms during weight-bearing activities.
Several conditions may increase COMP levels.
Progressive cartilage degeneration releases COMP into the bloodstream, making it one of the most studied biomarkers for osteoarthritis.
Inflammatory joint damage accelerates cartilage destruction, resulting in elevated COMP levels.
Ligament tears, cartilage injuries, and meniscal damage may temporarily increase COMP.
Repetitive mechanical stress from high-impact activities can increase cartilage turnover.
Natural cartilage wear associated with aging may gradually elevate COMP.
Certain connective tissue diseases involving cartilage and joint damage may increase COMP concentrations.
COMP is one of the most extensively researched biomarkers in osteoarthritis.
Higher COMP levels are often associated with:
Although COMP cannot diagnose osteoarthritis by itself, it provides valuable information when combined with clinical assessment and imaging.
Healthy cartilage is essential for smooth movement and joint stability.
Elevated COMP has been associated with:
Monitoring COMP may help identify individuals at increased risk of progressive joint deterioration.
COMP is measured using a simple blood test.
Most laboratories measure circulating COMP using specialized immunoassays such as ELISA.
Results are interpreted alongside:
COMP testing is commonly used in research settings and is increasingly being incorporated into advanced musculoskeletal assessment programs.
Reducing cartilage damage and supporting joint health may help maintain healthier COMP levels.
Reducing excess body weight decreases mechanical stress on weight-bearing joints.
Activities such as walking, swimming, and cycling help support healthy cartilage without excessive joint loading.
Improving muscle strength enhances joint stability and reduces cartilage stress.
A diet rich in vegetables, fruits, whole grains, healthy fats, and omega-3 fatty acids supports overall joint health.
Proper exercise technique, adequate recovery, and avoiding repetitive overload may reduce cartilage damage.
Early diagnosis and appropriate treatment of arthritis may help slow cartilage degeneration and reduce COMP elevation.
No. Elevated COMP can also occur with sports injuries, rheumatoid arthritis, ligament injuries, cartilage damage, and other musculoskeletal conditions.
Research suggests that COMP may increase before structural damage becomes clearly visible on imaging, making it a promising biomarker for early cartilage degeneration.
No. COMP should always be interpreted alongside symptoms, physical examination, imaging studies, and additional laboratory tests.
Healthcare providers may recommend repeat testing to monitor cartilage health, disease progression, or response to treatment depending on the clinical situation.
Cartilage Oligomeric Matrix Protein (COMP) is an important biomarker that reflects cartilage health and ongoing joint degeneration. Elevated COMP levels may indicate increased cartilage breakdown associated with osteoarthritis, sports injuries, inflammatory arthritis, or other musculoskeletal disorders.
When interpreted alongside symptoms, imaging, and other biomarkers, COMP provides valuable insight into joint health and helps healthcare providers make more informed treatment decisions.